Retinopathy - DiabetesontheNet

What are the baseline predictors of outcomes in people with DMO treated with ranibizumab?

Metabolic memory: The long-term results of early glycaemic control in type 1 diabetes

Ensuring the effective delivery of diabetic eye screening for children and young people in England

Mesenchymal stem cells: The future of the management of diabetic retinopathy

What is the best treatment for diabetic macular oedema?

Is the severity of DR predictive of cognitive impairment?

Cost-effective treatments for diabetic macular oedema

Targeted pan-retinal photocoagulation

Laser treatment still has a pivotal role in retinal disease

Ranibizumab or laser treatment for macular oedema?

Ocular effects of systemic therapies for managing diabetes

Laser treatment for maculopathy remains the standard treatment

Better management of maculopathy may reduce the prevalence of blindness in people with type 1 diabetes

Time, HbA1c and blood pressure: Influences on cumulative incidence of macular oedema

Candesartan: What effects on diabetic retinopathy?

Telephone intervention to promote diabetic retinopathy screening among the urban poor

Adding to the polypharmacy in type 2 diabetes?

US still have a long way to go in systematic retinopathy screening